Synonymous HTT CAA/CCA-loss variants associated with early Huntington disease onset enhance toxicity beyond somatic instability
Sequiera, G. L.; Gjervan, S. C.; McCallum, R.; Feng, J.; Ozgoren, O. K.; Bergh, S.; Begin, J.; Levesley, J.; Findlay Black, H.; Kay, C.; Soomarooah, T.; Arning, L.; Rajan Babu, I. S.; Basak, A. N.; Klempir, J.; Nguyen, H. P.; Petersen, A.; Hayden, M. R.; Pouladi, M. A.
Show abstract
Huntington disease is a fatal neurodegenerative disorder caused by CAG repeat expansion encoding polyglutamine in the HTT gene. Recent studies have shown that loss of CAA/CCA interruptions within polyglutamine-coding CAG tracts and adjacent polyproline-coding region are linked to earlier disease onset. It has been hypothesized that somatic repeat instability, influenced by these interrupted CAG tracts, may mediate this effect. Here we demonstrate that HTT CAA/CCA-loss variant linked to early disease onset exacerbates mutant HTT toxicity in cellular models through mechanisms independent of somatic repeat instability. The CAA/CCA-loss variant exhibits significantly higher toxicity than canonical HTT sequences in both transient expression and stable cell line models. Notably, this enhanced toxicity persists in knockout cells of the mismatch repair gene MSH3 where somatic instability is blunted, with a consistent toxicity hierarchy (CAA/CCA-loss > CCA-loss > CAA-loss > canonical HTT) in both wildtype and MSH3 knockout cells. Furthermore, the CAA/CCA-loss variant generates elevated levels of repeat-associated non-AUG (RAN) translation products. In HEK293-based cellular models, these results suggest that the disease-accelerating effects of HTT CAA/CCA-loss variants involve intrinsic properties of the altered sequence context, highlighting the importance of understanding sequence-specific mechanisms in HD pathogenesis beyond polyglutamine length and somatic instability.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease 94%
- Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice 92%
- Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic transcript dysregulation in vitro 92%
Similar papers in this journal
Similar papers in this journal
- Bioenergetic dysregulation in the basal ganglia and cerebellum of patients with premanifest and manifest Huntington's disease 92%
- Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression 91%
- A panel of TDP-43-regulated splicing events verify loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue 91%
Similar papers in this journal
- A meta-analysis of transcriptomic profiles from Huntington's disease patients substantiates the pathophysiological role of CDC42, NFY, DLX1 and PRMT3 95%
- Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease 94%
- Progranulin deficiency leads to reduced glucocerebrosidase activity 92%
Similar papers in this journal
- Depopulation of α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson disease model 94%
- TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy 93%
- Nuclear depletion of RNA binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.